BioMaxima S.A. (FRA:944)

BioMaxima Statistics

Total Valuation

BioMaxima has a market cap or net worth of EUR 12.05 million. The enterprise value is 15.80 million.

Market Cap	12.05M
Enterprise Value	15.80M

Important Dates

The last earnings date was Friday, November 28, 2025.

Earnings Date	Nov 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	4.19M
Shares Outstanding	n/a
Shares Change (YoY)	-8.25%
Shares Change (QoQ)	+3.57%
Owned by Insiders (%)	22.38%
Owned by Institutions (%)	n/a
Float	2.69M

Valuation Ratios

The trailing PE ratio is 79.20.

PE Ratio	79.20
Forward PE	n/a
PS Ratio	0.86
PB Ratio	1.10
P/TBV Ratio	1.11
P/FCF Ratio	223.47
P/OCF Ratio	25.56
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.72, with an EV/FCF ratio of 293.09.

EV / Earnings	103.87
EV / Sales	1.17
EV / EBITDA	13.72
EV / EBIT	48.35
EV / FCF	293.09

Financial Position

The company has a current ratio of 1.41, with a Debt / Equity ratio of 0.03.

Current Ratio	1.41
Quick Ratio	0.71
Debt / Equity	0.03
Debt / EBITDA	0.34
Debt / FCF	6.77
Interest Coverage	0.93

Financial Efficiency

Return on equity (ROE) is 1.38% and return on invested capital (ROIC) is 1.36%.

Return on Equity (ROE)	1.38%
Return on Assets (ROA)	0.85%
Return on Invested Capital (ROIC)	1.36%
Return on Capital Employed (ROCE)	1.80%
Revenue Per Employee	110,993
Profits Per Employee	1,207
Employee Count	126
Asset Turnover	0.78
Inventory Turnover	2.33

Taxes

Income Tax	-35,622
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -8.68% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-8.68%
50-Day Moving Average	2.60
200-Day Moving Average	2.66
Relative Strength Index (RSI)	31.29
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioMaxima had revenue of EUR 13.99 million and earned 152,096 in profits. Earnings per share was 0.04.

Revenue	13.99M
Gross Profit	6.59M
Operating Income	244,432
Pretax Income	116,474
Net Income	152,096
EBITDA	1.02M
EBIT	244,432
Earnings Per Share (EPS)	0.04

Balance Sheet

The company has 261,305 in cash and 364,655 in debt, giving a net cash position of -103,350.

Cash & Cash Equivalents	261,305
Total Debt	364,655
Net Cash	-103,350
Net Cash Per Share	n/a
Equity (Book Value)	10.97M
Book Value Per Share	2.53
Working Capital	1.86M

Cash Flow

In the last 12 months, operating cash flow was 471,287 and capital expenditures -417,385, giving a free cash flow of 53,902.

Operating Cash Flow	471,287
Capital Expenditures	-417,385
Free Cash Flow	53,902
FCF Per Share	n/a

Margins

Gross margin is 47.13%, with operating and profit margins of 1.75% and 1.09%.

Gross Margin	47.13%
Operating Margin	1.75%
Pretax Margin	0.83%
Profit Margin	1.09%
EBITDA Margin	7.27%
EBIT Margin	1.75%
FCF Margin	0.39%

Dividends & Yields

BioMaxima does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	8.25%
Shareholder Yield	8.25%
Earnings Yield	1.26%
FCF Yield	0.45%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6